HIKAL
Back to Balance Sheet
|
HIKAL Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹33 Cr | ₹30 Cr | ₹33 Cr | ₹36 Cr | ₹38 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of HIKAL ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹33 Cr |
| Mar2024 | ₹30 Cr |
| Mar2023 | ₹33 Cr |
| Mar2022 | ₹36 Cr |
| Mar2021 | ₹38 Cr |
How is Deferred Tax Assets / Liabilities of HIKAL Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹33 Cr | 8.33 | |
| Mar2024 | ₹30 Cr | -8.30 | |
| Mar2023 | ₹33 Cr | -10.14 | |
| Mar2022 | ₹36 Cr | -3.13 | |
| Mar2021 | ₹38 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of HIKAL
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| HIKAL | ₹3,017.8 Cr | 11.3% | 37.5% | -32.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹464,331.0 Cr | 1.2% | 8.3% | 15.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹181,466.0 Cr | -0.2% | 3% | -0.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹165,952.0 Cr | 1.7% | 9.9% | 46.8% | Stock Analytics | |
| CIPLA | ₹116,229.0 Cr | -2.2% | 4.5% | -4.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,959.0 Cr | -9% | -2.1% | -1.8% | Stock Analytics | |
HIKAL Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| HIKAL | 11.3% |
37.5% |
-32.8% |
| SENSEX | -0.3% |
4.9% |
-7% |
You may also like the below Video Courses